Prof. Dr. med. Boris Hadaschik

Prof. Dr. med. Boris Hadaschik is a highly accomplished urologist with over 21 years of experience. He is currently the Director and Chair of the Department of Urology at the University Hospital Essen in Germany. Dr. Hadaschik has an impressive educational background, having studied human medicine at the University of Heidelberg and in prestigious institutions in the United States. He obtained a medical license and successfully defended his dissertation. He later specialized in urology and obtained habilitation and a teaching license. One of the most remarkable aspects of Dr. Hadaschik's career is his extensive research and contributions to the field of urology. He has published 356 scientific publications, focusing on urological oncology and andrology. His research has covered many topics, including prostate cancer diagnostics, treatment decision-making, and novel treatment approaches. Dr. Hadaschik has been recognized for his contributions and received prestigious awards, including the German Urological Association's Highest Scientific Award and the Maximilian Nitze Prize. As the Vice Director of the West German Cancer Center Consortium and a co-founder of the Ginsburg Study Group, Dr. Hadaschik actively collaborates with international working groups to optimize prostate cancer diagnostics. He is also the Principal Investigator of the German multicentre PROBASE trial, which aims to evaluate risk-adapted prostate-specific antigen screening prospectively. With his exceptional expertise, dedication to research, and extensive clinical experience, Prof. Dr. med. Boris Hadaschik is considered a leading figure in the field of urology. His contributions to prostate cancer diagnostics and treatment decision-making make him highly skilled and respected among his peers.